Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis

Abstract

The liver is a very tolerogenic organ. It is continually exposed to a multitude of antigens and is able to promote an effective immune response against pathogens and simultaneously immune tolerance against self-antigens. In spite of strong peripheral and central tolerogenic mechanisms, loss of tolerance can occur in autoimmune liver diseases, such as autoimmune hepatitis (AIH) through a combination of genetic predisposition, environmental factors, and an imbalance in immunological regulatory mechanisms. The liver hosts several types of conventional resident antigen presenting cells (APCs) such as dendritic cells, B cells and macrophages (Kupffer cells), and unconventional APCs including liver sinusoidal endothelial cells, hepatic stellate cells and hepatocytes. By standard (direct presentation and cross-presentation) and alternative mechanisms (cross-dressing and MHC class II-dressing), liver APCs presents self-antigen to naive T cells in the presence of costimulation leading to an altered immune response that results in liver injury and inflammation. Additionally, the transport of antigens and antigen:MHC complexes by trogocytosis and extracellular vesicles between different cells in the liver contributes to enhance antigen presentation and amplify autoimmune response. Here, we focus on the impact of antigen presentation on the immune response in the liver and on the functional role of the immune cells in the induction of liver inflammation. A better understanding of these key pathogenic aspects could facilitate the establishment of novel therapeutic strategies in AIH.

Neutrophils as immune effector cells in antibody therapy in cancer

“…For example, transfer of MHC molecules and immunoglobulins has been observed between T cells, B cells, and antigen-presenting cells. [154][155][156][157][158] This allows lymphocytes to acquire different immune functions, such as antigen presentation 159 but may also affect immune activation by transfer of stimulatory or inhibitory receptors. 160 In addition, donor cells may lose cellular functions by the deprivation of their membrane proteins.…”

The Prognostic Significance of FKBP1A and Its Related Immune Infiltration in Liver Hepatocellular Carcinoma

“…Hepatocellular carcinoma and others can evade antitumor immune response by exploiting this physiological mechanism by expressing the corresponding ligands including PD-L1 in tumor and stromal cells [ 5 , 33 ]. Regular treatments for LIHC include surgery, radiation therapy and targeted therapies are based on tyrosine protein kinase inhibitors [ 17 , 34 ]. However, the prognosis of hepatocellular carcinoma is very poor due to drug resistance and frequent recurrence and metastasis.…”

B cells in autoimmune hepatitis: bystanders or central players?

“…While MHCI proteins are expressed by all nucleated cells and present proteasome-processed antigens of cytosolic and nuclear origin to CD8 + T cells, MHCII molecules are mainly expressed by professional antigen-presenting cells (APCs) like dendritic cells (DCs), macrohages, and B cells and present exogenous peptides processed by the endocytic pathway to CD4 + T cells [ 93 ]. Although the AIH-asociated polymorphisms vary between ethnic groups and geographical regions, they are located within the HLA-DR3 and HLA-DR4 loci encoding MHC class II molecules, thus suggesting a disease-driving role for CD4 + T cells [ 1 , 3 , 94 ]. Antigen presentation by B cells is considered a rate-limiting step for diverse autoimmune diseases by inducing activation of autoreactive T cells with the same specificity [ 95 ].…”